| HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, B7-H3 targeting CAR-TILs / Zhaotai InVivo Biomedicine |
NCT04842812: Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors |
|
|
| Recruiting | 1 | 40 | RoW | TILs and CAR-TILs targeting HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, or B7-H3 | Second Affiliated Hospital of Guangzhou Medical University, Guangdong Zhaotai InVivo Biomedicine Co. Ltd. | Liver Cancer, Lung Cancer, Breast Cancer, Colo-rectal Cancer, Brain Tumor, Solid Tumor, Adult, PD1, CTLA4 | 12/29 | 01/35 | | |
